Granulated sugar for adjuvant treatment of surgical wound infection due to multi-drug-resistant pathogens in a child with sarcoma: a case report and literature review

Infez Med. 2017 Dec 1;25(4):358-361.

Abstract

The use of sugar for treating wounds which are difficult to heal and positive to resistant pathogens has already been documented. The authors describe the successful treatment by direct instillation of granular sugar in the antibiotic-resistant infected surgical site wound of a child with sarcoma. Sugar instillation in the extended spectrum beta-lactamase (ESBL)-producing Enterobacter cloacae positive wound, in addition to systemic treatment with meropenem and levofloxacin, allowed culture negativization in six days and complete wound healing in 30 days. These results make the use of sugar an attractive option for wounds which are difficult to treat, even in an immunocompromised child.

Publication types

  • Case Reports

MeSH terms

  • Administration, Topical
  • Child
  • Combined Modality Therapy
  • Drug Resistance, Multiple, Bacterial
  • Enterobacter cloacae / drug effects*
  • Enterobacteriaceae Infections / drug therapy
  • Enterobacteriaceae Infections / therapy*
  • Humans
  • Immunocompromised Host
  • Levofloxacin / therapeutic use
  • Male
  • Meropenem
  • Neurilemmoma / complications*
  • Neurilemmoma / surgery
  • Soft Tissue Neoplasms / complications*
  • Soft Tissue Neoplasms / surgery
  • Sucrose / administration & dosage
  • Sucrose / therapeutic use*
  • Surgical Wound Infection / drug therapy
  • Surgical Wound Infection / therapy*
  • Thienamycins / therapeutic use
  • Wound Healing

Substances

  • Thienamycins
  • Sucrose
  • Levofloxacin
  • Meropenem